TrialEuropean journal of clinical pharmacology1991

Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study.

G Ciuffetti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.